Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response

Journal of Immunology

Volumn 164, Issue 10, 2000, Pages 5362-5368

  Matsukawa, Akihiro ^a   Hogaboam, Cory M ^a   Lukacs, Nickolas W ^a   Lincoln, Pamela M ^a   Evanoff, Holly L ^a   Kunkel, Steven L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BACTERICIDAL ACTIVITY; CHRONIC INFLAMMATION; ESCHERICHIA COLI; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RESPIRATORY BURST; SEPSIS;

EID: 0034658391     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.10.5362     Document Type: Article

References (39)

1. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
2. Hoffmann, J. A., F. C. Kafatos, C. A. Janeway, and R. A. Ezckowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284:1313.
3. Klebanoff, S. J., and R. A. Clark. 1978. The Neutrophils: Functional and Clinical Disorders. North-Holland, New York.
4. Aderem, A., and D. M. Underhill. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593.
5. Luster, A. D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
6. Proost, P., A. Wuyts, and J. van Damme. 1996. The role of chemokines in inflammation. Int. J. Clin. Lab. Res. 26:211.
7. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675.
8. Chantry, D., A. J. DeMaggio, H. Brammer, C. J. Raport, C. L. Wood, V. L. Schweickart, A. Epp, A. Smith, J. T. Stine, K. Walton, et al. 1998. Profile of human macrophage transcripts: insights into macrophage biology and identification of novel chemokines. J. Leukocyte Biol. 64:49.
9. Imai, T., D. Chantry, C. J. Raport, C. L. Wood, M. Nishimura, R. Godiska, O. Yoshie, and P. W. Gray. 1998. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273:1764.
10. Imai, T., M. Nagira, S. Takagi, M. Kakizaki, M. Nishimura, J. Wang, P. W. Gray, K. Matsushima, and O. Yoshie. 1999. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 11:81.
11. Gonzalo, J. A., Y. Pan, C. M. Lloyd, G. Q. Jia, G. Yu, B. Dussault, C. A. Powers, A. E. Proudfoot, A. J. Coyle, D. Gearing, and J. C. Gutierrez-Ramos. 1999. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J. Immunol. 163:403.
12. Vestergaard, C., H. Yoneyama, M. Murai, K. Nakamura, K. Tamaki, Y. Terashima, T. Imai, O. Yoshie, T. Irimura, H. Mizutani, and K. Matsushima. 1999. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104:1097.
13. low thymocytes. Blood 94:1890.
14. Godiska, R., D. Chantry, C. J. Raport, S. Sozzani, P. Allavena, D. Leviten, A. Mantovani, and P. W. Gray. 1997. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 185:1595.
15. Russell, D. G. 1995. Of microbes and macrophages: entry, survival and persistence. Curr. Opin. Immunol. 7:479.
16. Andrew, D. P., M. S. Chang, J. McNinch, S. T. Wathen, M. Rihanek, J. Tseng, J. P. Spellberg, and C. G. Elias III. 1998. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 161:5027.
17. Baumhofer, J. M., B. G. Beinhauer, J. E. Wang, H. Brandmeier, K. Geissler, U. Losert, R. Philip, G. Aversa, and M. A. Rogy. 1998. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur. J. Immunol. 28:610.
18. Muchamuel, T., S. Menon, P. Pisacane, M. C. Howard, and D. A. Cockayne. 1997. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-α, IFN-γ, and IL-12 production. J. Immunol. 158:2898.
19. Fink, M. P., and S. O. Heard. 1990. Laboratory models of sepsis and septic shock. J. Surg. Res. 49:186.
20. 2 production by human neutrophils: the preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol. 105:358.
21. Devi, S., J. Laning, Y. Luo, and M. E. Dorf. 1995. Biologic activities of the β-chemokine TCA3 on neutrophils and macrophages. J. Immunol. 154:5376.
22. Wright, D. G., and S. E. Malawista. 1972. The mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis. J. Cell Biol. 53:788.
23. Hogaboam, C. M., M. L. Steinhauser, H. Schock, N. W. Lukacs, R. M. Strieter, T. J. Standiford, and S. L. Kunkel. 1998. Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: role of interleukin-10 and monocyte chemoattractant protein 1. Infect. Immunol. 66:650.
24. Ruth, J. H., N. W. Lukacs, K. S. Warmington, T. J. Polak, M. Burdick, S. L. Kunkel, R. M. Strieter, and S. W. Chensue. 1998. Expression and participation of eotaxin during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation. J. Immunol. 161:4276.
25. Badwey, J. A., and M. L. Karnovsky. 1980. Active oxygen species and the functions of phagocytic leukocytes. Annu. Rev. Biochem. 49:695.
26. Cardella, C. J., P. Davies, and A. C. Allison. 1974. Immune complexes induce selective release of lysosomal hydrolases from macrophages. Nature 247:46.
27. Bone, R. C. 1996. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome. Ann. Intern. Med. 125:680.
28. Nelson, S., and W. R. Summer. 1998. Innate immunity, cytokines, and pulmonary host defense. Infect. Dis. Clin. North Am. 12:555.
29. Matsukawa, A., C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, R. M. Strieter, and S. L. Kunkel. 1999. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J. Immunol. 163:6148.
30. Nakano, Y., T. Kasahara, N. Mukaida, Y. C. Ko, M. Nakano, and K. Matsushima. 1994. Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor. Infect. Immun. 62:377.
31. Matsushima, K., C. G. Larsen, G. C. DuBois, and J. J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169:1485.
32. Rollins, B. J., A. Walz, and M. Baggiolini. 1991. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78:1112.
33. Hack, C. E., L. A. Aarden, and L. G. Thijs. 1997. Role of cytokines in sepsis. Adv. Immunol. 66:101.
34. Tracey, K. J. 1994. Tumor necrosis factor-α. In The Cytokine Handbook. A. Thompson, ed. Academic, London, pp. 289-304.
35. Essner, R., K. Rhoades, W. H. McBride, D. L. Morton, and J. S. Economou. 1989. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J. Immunol. 142:3857.
36. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
37. de Waal Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151:6370.
38. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644.
39. Astiz, M. E., and E. C. Rackow. 1998. Septic shock. Lancet 351:1501.